Jubilant Pharmova Limited has informed the Exchange about USFDA CommunicationPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a press release pertaining to……
| Subscribe To Our Free Newsletter |
